{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:22:13Z","timestamp":1790882533095,"version":"4.1.0"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["PR9"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Neuropathic pain can be caused by a lesion or disease of the somatosensory system characterised by pathological neuro-immune alterations. At a molecular level, microRNAs (miRNAs) act as regulators of gene expression orchestrating both immune and neuronal processes. Thus, miRNAs may act as essential modulators of processes for the establishment and maintenance of neuropathic pain. The objective\/aims of this scoping review was to explore and chart the literature to identify miRNAs that are dysregulated in neuropathic pain. The following databases were searched from inception to March 2023: PubMed, EBSCO, CINAHL, Cochrane Library, and SCOPUS. Two independent reviewers screened, extracted data, and independently assessed the risk of bias in included studies. The JBI critical appraisal checklist was used for critical appraisal. A narrative synthesis was used to summarise the evidence. Seven studies (total of 384 participants) that met our eligibility criteria were included in this scoping review. Our review has identified different miRNAs that are commonly involved in the chronic neuropathic pain conditions including miR-132, miR-101, and miR-199a. Our review findings further suggest that expression of miRNAs to be significantly associated with increased diabetic disease duration, HbA1C levels, and fibrinogen levels. Our review findings suggest that there is clear association between miRNA expression and chronic neuropathic pain conditions. Therefore, increasing the specificity by selecting a candidate miRNA and identifying its target mRNA is an area of future research.<\/jats:p>","DOI":"10.1097\/pr9.0000000000001108","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T13:00:40Z","timestamp":1699016440000},"page":"e1108","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["The role of micro-RNAs in neuropathic pain\u2014a scoping review"],"prefix":"10.1097","volume":"8","author":[{"given":"Kesava","family":"Kovanur Sampath","sequence":"first","affiliation":[{"name":"Centre for Health and Social Practice, Waikato Institute of Technology, Hamilton, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzie","family":"Belcher","sequence":"additional","affiliation":[{"name":"Centre for Health and Social Practice, Waikato Institute of Technology, Hamilton, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Hales","sequence":"additional","affiliation":[{"name":"Centre for Health and Social Practice, Waikato Institute of Technology, Hamilton, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver P.","family":"Thomson","sequence":"additional","affiliation":[{"name":"Research Centre, University College of Osteopathy, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Farrell","sequence":"additional","affiliation":[{"name":"Centre for Health Activity and Rehabilitation Research, School of Physiotherapy, Otago University, Dunedin, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Spontelli","family":"Gisselman","sequence":"additional","affiliation":[{"name":"Doctor of Physical Therapy Program, Department of Public Health and Community Medicine, School of Medicine, Tufts University, Phoenix, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Katare","sequence":"additional","affiliation":[{"name":"Department of Physiology, HeartOtago, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Tumilty","sequence":"additional","affiliation":[{"name":"Centre for Health Activity and Rehabilitation Research, School of Physiotherapy, Otago University, Dunedin, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,12]]},"reference":[{"key":"R1-20240807","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.2337\/dc11-1108","article-title":"Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K","volume":"34","author":"Abbott","year":"2011","journal-title":"Diabetes Care"},{"key":"R2-20240807","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/pme.12066","article-title":"The miRNA and mRNA changes in rat hippocampi after chronic constriction injury","volume":"14","author":"Arai","year":"2013","journal-title":"Pain Med"},{"key":"R3-20240807","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework","volume":"8","author":"Arksey","year":"2005","journal-title":"Int J Soc Res Methodol"},{"key":"R4-20240807","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.imlet.2021.01.007","article-title":"Determination of the transcriptional level of long non-coding RNA NEAT-1, downstream target microRNAs, and genes targeted by microRNAs in diabetic neuropathy patients","volume":"232","author":"Asadi","year":"2021","journal-title":"Immunol Lett"},{"key":"R5-20240807","doi-asserted-by":"crossref","first-page":"e09178","DOI":"10.1016\/j.heliyon.2022.e09178","article-title":"The axis of long non-coding RNA MALAT1\/miR-1-3p\/CXCR4 is dysregulated in patients with diabetic neuropathy","volume":"8","author":"Ashjari","year":"2022","journal-title":"Heliyon"},{"key":"R6-20240807","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S1474-4422(12)70189-8","article-title":"Subgrouping of patients with neuropathic pain according to pain-related sensory abnormalities: a first step to a stratified treatment approach","volume":"11","author":"Baron","year":"2012","journal-title":"Lancet Neurol"},{"key":"R7-20240807","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3390\/jcm11030612","article-title":"Salivary MicroRNA signature for diagnosis of endometriosis","volume":"11","author":"Bendifallah","year":"2022","journal-title":"J Clin Med"},{"key":"R8-20240807","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.nlm.2011.04.004","article-title":"MicroRNA regulation of neural plasticity and memory","volume":"96","author":"Bredy","year":"2011","journal-title":"Neurobiol Learn Mem"},{"key":"R9-20240807","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejpain.2005.06.009","article-title":"Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment","volume":"10","author":"Breivik","year":"2006","journal-title":"Eur J Pain"},{"key":"R10-20240807","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neubiorev.2015.10.010","article-title":"Environmental control of microRNAs in the nervous system: implications in plasticity and behavior","volume":"60","author":"Codocedo","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"key":"R11-20240807","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3233\/JAD-2008-14103","article-title":"Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways","volume":"14","author":"Cogswell","year":"2008","journal-title":"J Alzheimers Dis"},{"key":"R12-20240807","doi-asserted-by":"crossref","first-page":"17002","DOI":"10.1038\/nrdp.2017.2","article-title":"Neuropathic pain","volume":"3","author":"Colloca","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"R13-20240807","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1744-8069-4-35","article-title":"Descending serotonergic controls regulate inflammation-induced mechanical sensitivity and methyl-CpG-binding protein 2 phosphorylation in the rat superficial dorsal horn","volume":"4","author":"G\u00e9ranton","year":"2008","journal-title":"Mol Pain"},{"key":"R14-20240807","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrendo.2013.86","article-title":"Circulating microRNAs as novel biomarkers for diabetes mellitus","volume":"9","author":"Guay","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"R15-20240807","doi-asserted-by":"crossref","first-page":"8622388","DOI":"10.1155\/2022\/8622388","article-title":"miRNA-22 upregulates Mtf1 in dorsal horn neurons and is essential for inflammatory pain","volume":"2022","author":"Hao","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"R16-20240807","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12974-016-0712-6","article-title":"miR-124a and miR-155 enhance differentiation of regulatory T cells in patients with neuropathic pain","volume":"13","author":"Heyn","year":"2016","journal-title":"J Neuroinflammation"},{"key":"R17-20240807","doi-asserted-by":"crossref","first-page":"108508","DOI":"10.1016\/j.intimp.2021.108508","article-title":"miR-185-5p alleviates CCI-induced neuropathic pain by repressing NLRP3 inflammasome through dual targeting MyD88 and CXCR4","volume":"104","author":"Huang","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"R18-20240807","doi-asserted-by":"crossref","first-page":"e53823","DOI":"10.1371\/journal.pone.0053823","article-title":"Systematic transcriptome wide analysis of lncRNA-miRNA interactions","volume":"8","author":"Jalali","year":"2013","journal-title":"PLoS One"},{"key":"R19-20240807","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/jcb.26269","article-title":"MiR-150 alleviates neuropathic pain via inhibiting toll-like receptor 5","volume":"119","author":"Ji","year":"2018","journal-title":"J Cell Biochem"},{"key":"R20-20240807","doi-asserted-by":"crossref","first-page":"738530","DOI":"10.3389\/fneur.2021.738530","article-title":"Profiling of differentially expressed MicroRNAs in saliva of Parkinson's disease patients","volume":"12","author":"Jiang","year":"2021","journal-title":"Front Neurol"},{"key":"R21-20240807","doi-asserted-by":"crossref","first-page":"NS20190099","DOI":"10.1042\/NS20190099","article-title":"Non-coding RNAs in neuropathic pain","volume":"4","author":"Kalpachidou","year":"2020","journal-title":"Neuronal Signal"},{"key":"R22-20240807","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/nn2010","article-title":"Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA","volume":"10","author":"Klein","year":"2007","journal-title":"Nat Neurosci"},{"key":"R23-20240807","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fnmol.2013.00033","article-title":"microRNAs in nociceptive circuits as predictors of future clinical applications","volume":"6","author":"Kress","year":"2013","journal-title":"Front Mol Neurosci"},{"key":"R24-20240807","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41598-017-18657-4","article-title":"Functional brain network mechanism of hypersensitivity in chronic pain","volume":"8","author":"Lee","year":"2018","journal-title":"Scientific Rep"},{"key":"R25-20240807","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.expneurol.2016.06.025","article-title":"Increased miR-132-3p expression is associated with chronic neuropathic pain","volume":"283","author":"Leinders","year":"2016","journal-title":"Exp Neurol"},{"key":"R26-20240807","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1161\/CIRCRESAHA.120.317604","article-title":"Exercise regulates MicroRNAs to preserve coronary and cardiac function in the diabetic heart","volume":"127","author":"Lew","year":"2020","journal-title":"Circ Res"},{"key":"R27-20240807","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.3892\/mmr.2017.6874","article-title":"miR\u2011199a\u20113p is involved in the pathogenesis and progression of diabetic neuropathy through downregulation of SerpinE2","volume":"16","author":"Li","year":"2017","journal-title":"Mol Med Rep"},{"key":"R28-20240807","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1124\/jpet.115.231670","article-title":"Targeting epigenetic mechanisms for chronic pain: a valid approach for the development of novel therapeutics","volume":"357","author":"Ligon","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"R29-20240807","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/kjm2.12025","article-title":"MiR-101 relates to chronic peripheral neuropathic pain through targeting KPNB1 and regulating NF-\u03baB signaling","volume":"35","author":"Liu","year":"2019","journal-title":"Kaohsiung J Med Sci"},{"key":"R30-20240807","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2017.06.001","article-title":"MicroRNA and chronic pain: from mechanisms to therapeutic potential","volume":"180","author":"L\u00f3pez-Gonz\u00e1lez","year":"2017","journal-title":"Pharmacol Ther"},{"key":"R31-20240807","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.fob.2015.08.010","article-title":"MicroRNAs downregulated in neuropathic pain regulate MeCP2 and BDNF related to pain sensitivity","volume":"5","author":"Manners","year":"2015","journal-title":"FEBS Open Bio"},{"key":"R32-20240807","doi-asserted-by":"crossref","first-page":"e12715","DOI":"10.7717\/peerj.12715","article-title":"Salivary miRNAs as non-invasive biomarkers of hepatocellular carcinoma: a pilot study","volume":"10","author":"Mariam","year":"2022","journal-title":"PeerJ"},{"key":"R33-20240807","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1476-4598-5-24","article-title":"Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies","volume":"5","author":"Mattie","year":"2006","journal-title":"Mol Cancer"},{"key":"R35-20240807","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/1479-5876-9-195","article-title":"MicroRNA modulation in complex regional pain syndrome","volume":"9","author":"Orlova","year":"2011","journal-title":"J Translational Med"},{"key":"R36-20240807","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"R37-20240807","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejphar.2011.04.014","article-title":"Minocycline attenuates the development of diabetic neuropathic pain: possible anti-inflammatory and anti-oxidant mechanisms","volume":"661","author":"Pabreja","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"R38-20240807","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.imlet.2022.03.004","article-title":"The MALAT1-H19\/miR-19b-3p axis can be a fingerprint for diabetic neuropathy","volume":"245","author":"Rajabinejad","year":"2022","journal-title":"Immunol Lett"},{"key":"R39-20240807","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/bs.apha.2015.12.001","article-title":"MicroRNA-based biomarkers in pain","volume":"75","author":"Ramanathan","year":"2016","journal-title":"Adv Pharmacol"},{"key":"R40-20240807","doi-asserted-by":"crossref","first-page":"9.25.1","DOI":"10.1002\/cpph.29","article-title":"Overview of microRNA modulation in analgesic research","volume":"79","author":"Ramanathan","year":"2017","journal-title":"Curr Protoc Pharmacol"},{"key":"R41-20240807","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jpain.2021.12.007","article-title":"Microvascular barrier protection by microRNA-183 via FoxO1 repression: a pathway disturbed in neuropathy and complex regional pain syndrome","volume":"23","author":"Reinhold","year":"2022","journal-title":"J Pain"},{"key":"R42-20240807","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/j.1532-2149.2013.00332.x","article-title":"The prevalence of widespread central hypersensitivity in chronic pain patients","volume":"17","author":"Schliessbach","year":"2013","journal-title":"Eur J Pain"},{"key":"R43-20240807","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/j.pain.0000000000001365","article-title":"The IASP classification of chronic pain for ICD-11: chronic neuropathic pain","volume":"160","author":"Scholz","year":"2019","journal-title":"PAIN"},{"key":"R44-20240807","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2174\/156720512800492512","article-title":"Threshold-independent meta-analysis of Alzheimer's disease transcriptomes shows progressive changes in hippocampal functions, epigenetics and microRNA regulation","volume":"9","author":"Barbash","year":"2012","journal-title":"Curr Alzheimer Res"},{"key":"R45-20240807","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.molmed.2011.06.009","article-title":"NeurimmiRs: microRNAs in the neuroimmune interface","volume":"17","author":"Soreq","year":"2011","journal-title":"Trends Mol Med"},{"key":"R46-20240807","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/bja\/ael209","article-title":"Alleviation of neuropathic pain by intrathecal injection of antisense oligonucleotides to p65 subunit of NF-kappaB","volume":"97","author":"Sun","year":"2006","journal-title":"Br J Anaesth"},{"key":"R47-20240807","doi-asserted-by":"crossref","first-page":"1744806919860323","DOI":"10.1177\/1744806919860323","article-title":"Correlation of miRNA expression with intensity of neuropathic pain in man","volume":"15","author":"Tavares-Ferreira","year":"2019","journal-title":"Mol Pain"},{"key":"R48-20240807","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1744-8069-8-14","article-title":"The expression of spinal methyl-CpG-binding protein 2, DNA methyltransferases and histone deacetylases is modulated in persistent pain states","volume":"8","author":"Tochiki","year":"2012","journal-title":"Mol Pain"},{"key":"R49-20240807","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"R50-20240807","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrneurol.2011.137","article-title":"Diabetic neuropathy: cellular mechanisms as therapeutic targets","volume":"7","author":"Vincent","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"R51-20240807","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s11064-020-03213-w","article-title":"MiR-122-5p suppresses neuropathic pain development by targeting PDK4","volume":"46","author":"Wan","year":"2021","journal-title":"Neurochem Res"},{"key":"R52-20240807","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.intimp.2017.01.027","article-title":"MicroRNA-93 alleviates neuropathic pain through targeting signal transducer and activator of transcription 3","volume":"46","author":"Yan","year":"2017","journal-title":"Int Immunopharmacol"},{"key":"R53-20240807","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12990-015-0015-4","article-title":"MeCP2 plays an analgesic role in pain transmission through regulating CREB\/miR-132 pathway","volume":"11","author":"Zhang","year":"2015","journal-title":"Mol Pain"},{"key":"R54-20240807","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/bab.1854","article-title":"MicroRNA\u2010144 relieves chronic constriction injury\u2010induced neuropathic pain via targeting RASA1","volume":"67","author":"Zhang","year":"2020","journal-title":"Biotechnol Appl Biochem"},{"key":"R55-20240807","doi-asserted-by":"crossref","first-page":"134946","DOI":"10.1016\/j.neulet.2020.134946","article-title":"MicroRNA-128-3p alleviates neuropathic pain through targeting ZEB1","volume":"729","author":"Zhang","year":"2020","journal-title":"Neurosci Lett"},{"key":"R56-20240807","first-page":"501","article-title":"MicroRNA-142-3p relieves neuropathic pain by targeting high mobility group box 1","volume":"41","author":"Zhang","year":"2018","journal-title":"Int J Mol Med"}],"container-title":["PAIN Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PR9.0000000000001108","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T09:38:19Z","timestamp":1730453899000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PR9.0000000000001108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,2]]},"references-count":55,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/pr9.0000000000001108","relation":{},"ISSN":["2471-2531"],"issn-type":[{"value":"2471-2531","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,2]]},"assertion":[{"value":"2022-12-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}